95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Johannes Schetelig1,2*
Henning Baldauf2Linda Koster3Michelle Kuxhausen4Falk Heidenreich1,2Liesbeth C. de Wreede2,5Stephen Spellman4Michel van Gelder6Benedetto Bruno7Francesco Onida8Vinzenz Lange9Carolin Massalski9Victoria Potter10Per Ljungman11Nicolaas Schaap12Patrick Hayden13Stephanie J. Lee14Nicolaus Kröger15Kathy Hsu16Alexander H. Schmidt2,9Ibrahim Yakoub-Agha17Marie Robin18- 1Medizinische Klinik und Poliklinik I, University Hospital Dresden, Dresden, Germany
- 2DKMS Clinical Trials Unit, Dresden, Germany
- 3EBMT Data Office Leiden, Leiden, Netherlands
- 4Center for International Blood and Marrow Transplant Research, Minneapolis, MN, United States
- 5Leiden University Medical Center, Department of Biomedical Data Sciences, Leiden, Netherlands
- 6Maastricht University Medical Center, Department of Internal Medicine, Maastricht, Netherlands
- 7A.O.U. Citta della Salute e della Scienza di Torino, Turin, Italy
- 8Fondazione IRCCS Ca’Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
- 9DKMS Life Science Lab, Dresden, Germany
- 10GKT School of Medicine, London, United Kingdom
- 11Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
- 12Radboud University Medical Centre, Nijmegen, Netherlands
- 13St. James’s Hospital, Dublin, Ireland
- 14Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- 15University Hospital Eppendorf, Hamburg, Germany
- 16Memorial Sloan Kettering Cancer Center, New York & Scientific Director, CIBMTR Immunobiology Working Committee, New York City, NY, United States
- 17CHU de Lille, LIRIC, INSERM U995, Universite´ de Lille, Lille, France
- 18Hopital Saint-Louis, APHP, Universite´ de Paris, Paris, France
By Schetelig J, Baldauf H, Koster L, Kuxhausen M, Heidenreich F, de Wreede LC, Spellman S, van Gelder M, Bruno B, Onida F, Lange V, Massalski C, Potter V, Ljungman P, Schaap N, Hayden P, Lee SJ, Kröger N, Hsu K, Schmidt AH, Yakoub-Agha I, Robin M. (2021) Front. Immunol. 11:584520. doi: 10.3389/fimmu.2020.584520
There is an error in the Funding statement. The CIBMTR support erroneously included the grant number OT3HL147741 that is not associated with this work.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: KIR, KIR2DS1, KIR3DL1, hematopoietic stem cell transplantation, donor selection, unrelated donor
Citation: Schetelig J, Baldauf H, Koster L, Kuxhausen M, Heidenreich F, de Wreede LC, Spellman S, van Gelder M, Bruno B, Onida F, Lange V, Massalski C, Potter V, Ljungman P, Schaap N, Hayden P, Lee SJ, Kröger N, Hsu K, Schmidt AH, Yakoub-Agha I and Robin M (2021) Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia. Front. Immunol. 12:813838. doi: 10.3389/fimmu.2021.813838
Received: 12 November 2021; Accepted: 01 December 2021;
Published: 21 December 2021.
Edited and reviewed by:
Marina Cella, Washington University School of Medicine in St. Louis, United StatesCopyright © 2021 Schetelig, Baldauf, Koster, Kuxhausen, Heidenreich, de Wreede, Spellman, van Gelder, Bruno, Onida, Lange, Massalski, Potter, Ljungman, Schaap, Hayden, Lee, Kröger, Hsu, Schmidt, Yakoub-Agha and Robin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Johannes Schetelig, am9oYW5uZXMuc2NoZXRlbGlnQHVrZGQuZGU=